Cargando…

Ligand-specific regulation of the extracellular surface of a G protein coupled receptor

G protein coupled receptors (GPCRs) are seven transmembrane proteins that mediate the majority of cellular responses to hormones and neurotransmitters. They are the largest group of therapeutic targets for a broad spectrum of diseases. Recent crystal structures of GPCRs1,2,3,4,5 reveal structural co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bokoch, Michael P., Zou, Yaozhong, Rasmussen, Søren G. F., Liu, Corey W., Nygaard, Rie, Rosenbaum, Daniel M., Fung, Juan José, Choi, Hee-Jung, Thian, Foon Sun, Kobilka, Tong Sun, Puglisi, Joseph D., Weis, William I., Pardo, Leonardo, Prosser, R. Scott, Mueller, Luciano, Kobilka, Brian K.
Formato:	Texto
Lenguaje:	English
Publicado:	2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805469/ https://www.ncbi.nlm.nih.gov/pubmed/20054398 http://dx.doi.org/10.1038/nature08650

Ejemplares similares

Structure of the δ-opioid receptor bound to naltrindole
por: Granier, Sébastien, et al.
Publicado: (2012)

Crystal structure of the μ-opioid receptor bound to a morphinan antagonist
por: Manglik, Aashish, et al.
Publicado: (2012)

N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor
por: Zou, Yaozhong, et al.
Publicado: (2012)

Structure of a nanobody-stabilized active state of the β(2) adrenoceptor
por: Rasmussen, Søren G. F., et al.
Publicado: (2011)

Crystal Structure of the β(2)Adrenergic Receptor-Gs protein complex
por: Rasmussen, Søren G.F., et al.
Publicado: (2011)

Ligand-regulated oligomerization of β(2)-adrenoceptors in a model lipid bilayer
por: Fung, Juan José, et al.
Publicado: (2009)

Applications of molecular replacement to G protein-coupled receptors
por: Kruse, Andrew C., et al.
Publicado: (2013)

Cryo-EM structure of the activated GLP-1 receptor in complex with G protein
por: Zhang, Yan, et al.
Publicado: (2017)

Structural Insights into Metabotropic Glutamate Receptor Activation
por: Koehl, Antoine, et al.
Publicado: (2019)

Structural basis of α(1A)-adrenergic receptor activation and recognition by an extracellular nanobody
por: Toyoda, Yosuke, et al.
Publicado: (2023)

Conformational dynamics of the μ-opioid receptor determine ligand intrinsic efficacy
por: Zhao, Jiawei, et al.
Publicado: (2023)

Identifying and quantifying two ligand-binding sites while imaging native human membrane receptors by AFM
por: Pfreundschuh, Moritz, et al.
Publicado: (2015)

Local membrane charge regulates β(2) adrenergic receptor coupling to G(i3)
por: Strohman, M. J., et al.
Publicado: (2019)

Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist
por: Sun, Bingfa, et al.
Publicado: (2021)

Allosteric coupling from G protein to the agonist binding pocket in GPCRs
por: DeVree, Brian T., et al.
Publicado: (2016)

Adrenaline-activated structure of the β(2)-adrenoceptor stabilized by an engineered nanobody
por: Ring, Aaron M., et al.
Publicado: (2013)

An improved yeast surface display platform for the screening of nanobody immune libraries
por: Uchański, Tomasz, et al.
Publicado: (2019)

Structure and Function of an Irreversible Agonist-β(2) Adrenoceptor complex
por: Rosenbaum, Daniel M., et al.
Publicado: (2011)

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist
por: Kawai, Takahiro, et al.
Publicado: (2020)

A Research Module for the Organic Chemistry Laboratory: Multistep Synthesis of a Fluorous Dye Molecule
por: Slade, Michael C., et al.
Publicado: (2014)

Single-molecule analysis of ligand efficacy in β(2)AR-G protein activation
por: Gregorio, G. Glenn, et al.
Publicado: (2017)

High-resolution crystal structure of human Protease-Activated Receptor 1 bound to the antagonist vorapaxar
por: Zhang, Cheng, et al.
Publicado: (2012)

Structure and Dynamics of the M(3) Muscarinic Acetylcholine Receptor
por: Kruse, Andrew C., et al.
Publicado: (2012)

Structure of the human M(2) muscarinic acetylcholine receptor bound to an antagonist
por: Haga, Kazuko, et al.
Publicado: (2012)

Signaling from β(1)- and β(2)-adrenergic receptors is defined by differential interactions with PDE4
por: Richter, Wito, et al.
Publicado: (2008)

Identification of GPCR-Interacting Cytosolic Proteins Using HDL Particles and Mass Spectrometry-Based Proteomic Approach
por: Chung, Ka Young, et al.
Publicado: (2013)

Structural insights into binding specificity, efficacy and bias of a β(2)AR partial agonist
por: Masureel, Matthieu, et al.
Publicado: (2018)

Phosphodiesterase 4D disruption causes β2 adrenergic receptors to behave like β1 adrenergic receptors in vivo
por: Pearl, N, et al.
Publicado: (2006)

The pathway of ligand entry from the membrane bilayer to a lipid G protein-coupled receptor
por: Stanley, Nathaniel, et al.
Publicado: (2016)

Allosteric Nanobodies Reveal the Dynamic Range and Diverse Mechanisms of GPCR Activation
por: Staus, Dean P, et al.
Publicado: (2016)

Ligand modulation of sidechain dynamics in a wild-type human GPCR
por: Clark, Lindsay D, et al.
Publicado: (2017)

Structure of active β-arrestin1 bound to a G protein-coupled receptor phosphopeptide
por: Shukla, Arun K., et al.
Publicado: (2013)

Organization of β-adrenoceptor signaling compartments by sympathetic innervation of cardiac myocytes
por: Shcherbakova, Olga G., et al.
Publicado: (2007)

Allosteric Modulation of G Protein Coupled Receptors by Cytoplasmic, Transmembrane and Extracellular Ligands
por: Yanamala, Naveena, et al.
Publicado: (2010)

Structures of Gα Proteins in Complex with Their Chaperone Reveal Quality Control Mechanisms
por: Seven, Alpay Burak, et al.
Publicado: (2020)

Structure‐Based Evolution of G Protein‐Biased μ‐Opioid Receptor Agonists
por: Wang, Haoqing, et al.
Publicado: (2022)

Developing Traditional Chinese Medicine in the Era of Evidence-Based Medicine: Current Evidences and Challenges
por: Fung, Foon Yin, et al.
Publicado: (2015)

Response to Revisiting: “Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting”
por: Fung, Foon Yin, et al.
Publicado: (2021)

Structural determinants of dual incretin receptor agonism by tirzepatide
por: Sun, Bingfa, et al.
Publicado: (2022)

Ligand chain length drives activation of lipid G protein-coupled receptors
por: Troupiotis-Tsaïlaki, Anastassia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_oc7griqlpetkdnth24re1n899q